Noctesia
Food supplement declared in France, declaration No 2022-1-449
Noctesia is a food supplement declared in France. Status: retiré du marché le 23 June 2025. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- PILEJE
- Status
- Retiré du marché le 23 June 2025
- Form
- Comprimé
- Daily dose
- 3 comprimés
- Directions for use
- 2 à 3 comprimés par jour, à avaler, à prendre au moment du coucher avec un grand verre d'eau.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous antidépresseurs, Sous traitement médicamenteux
- Objectives stated by the manufacturer (these are not authorised claims)
- Sommeil
Declaration 268914, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 23 June 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Eschscholzia californica Cham. | Parties aériennes fleurie | Extrait sec hydroalcoolique | 847 mg |
| Valeriana officinalis L. | Racine | Extrait sec hydroalcoolique | 353 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Fibres solubles d'acacia | not declared |
Additives
E460, E470b, E468, E341, Hydroxypropyl Méthyl Cellulose, E1200, E570, E471
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Un suivi médical est recommandé en cas d'usage concomitant de traitements psychotropes (anxiolytiques, hypnotiques, antidépresseurs).Déconseillé aux femmes enceintes ou allaitantes et aux enfants de moins de 12 ans.Une consommation excessive peut avoir des effets laxatifs.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.